| Literature DB >> 26793297 |
Jonna Maria Eriksson1, Sebastian Lundström2, Paul Lichtenstein3, Susanne Bejerot4, Elias Eriksson5.
Abstract
BACKGROUND: Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are neurodevelopmental disorders thought to have both genetic and environmental causes. It has been hypothesized that exposure to elevated levels of prenatal testosterone is associated with elevated traits of ASD and ADHD. Assuming that testosterone levels from a dizygotic male twin fetus may lead to enhanced testosterone exposure of its co-twins, we aimed to test the prenatal testosterone hypothesis by comparing same-sex with opposite-sex dizygotic twins with respect to neurodevelopmental symptoms.Entities:
Keywords: Asperger syndrome; Attention-deficit hyperactivity disorders; Autistic disorder; Symptom assessment; Twin study
Mesh:
Substances:
Year: 2016 PMID: 26793297 PMCID: PMC4719693 DOI: 10.1186/s13229-016-0074-z
Source DB: PubMed Journal: Mol Autism Impact factor: 7.509
Distribution of scores (%) for index twins with either a female or male co-twin
| ADHD | ASD | |||||||
|---|---|---|---|---|---|---|---|---|
| FF | FM | MF | MM | FF | FM | MF | MM | |
| 0 | 45.1 | 47.4 | 34.2 | 35.5 | 55.7 | 60.6 | 47.7 | 48.2 |
| 0.5 | 11.3 | 11.6 | 10.0 | 10.0 | 17.8 | 16.7 | 17.2 | 17.5 |
| 1 | 8.2 | 8.9 | 7.6 | 8.2 | 11.1 | 9.3 | 12.7 | 11.5 |
| 1.5 | 6.3 | 6.1 | 5.9 | 6.1 | 4.8 | 4.6 | 6.0 | 6.2 |
| 2 | 4.8 | 5.4 | 5.7 | 4.7 | 3.4 | 2.8 | 4.8 | 4.8 |
| 2.5 | 3.2 | 3.7 | 4.9 | 4.8 | 1.5 | 1.5 | 2.3 | 2.8 |
| 3 | 3.4 | 3.1 | 4.0 | 3.9 | 1.6 | 1.2 | 2.0 | 1.7 |
| 3.5 | 3.1 | 2.2 | 3.5 | 3.1 | 0.9 | 0.6 | 1.1 | 1.6 |
| 4 | 2.3 | 2.0 | 2.7 | 2.9 | 0.6 | 0.6 | 0.9 | 0.9 |
| 4.5–5 | 2.9 | 2.7 | 5.4 | 5.5 | 0.9 | 0.5 | 1.7 | 1.2 |
| 5.5–6 | 2.5 | 2.3 | 3.7 | 3.6 | 0.4 | 0.4 | 0.9 | 0.8 |
| 6.5–7 | 1.7 | 1.2 | 2.9 | 2.7 | 0.3 | 0.3 | 0.7 | 0.8 |
| 7.5–8 | 1.0 | 0.7 | 1.9 | 1.5 | 0.2 | 0.1 | 0.6 | 0.4 |
| >8 | 4.0 | 2.7 | 7.5 | 6.9 | 0.5 | 0.6 | 1.4 | 1.4 |
ADHD and ASD scores from the Autism—Tics, AD/HD, and other Comorbidities inventory (A-TAC)
FF female with a female co-twin, FM female with a male co-twin, MF male with female co-twin, MM male with a male co-twin
Differences in autistic and ADHD traits between index twins with either a female or a male co-twin
| Female co-twin | Male co-twin | |||||||
|---|---|---|---|---|---|---|---|---|
| Index twin |
| Mean rank |
| Mean rank | Mann–Whitney |
|
| |
| ADHD traits | Female | 1793 | 3063 | 4195 | 2961 | 3,626,673 | 0.03 | 0.03 |
| Male | 4190 | 3179 | 2109 | 3091 | 4,295,000 | 0.06 | 0.02 | |
| Autistic traits | Female | 1795 | 3099 | 4197 | 2953 | 3,582,249 | 0.001 | 0.04 |
| Male | 4197 | 3160 | 2115 | 3150 | 4,425,446 | 0.8 | – | |
ADHD and autistic traits measured by the Autism—Tics, AD/HD, and other Comorbidities inventory (A-TAC). r effect size
Number of children, n (%), with scores for ADHD and autistic traits above validated cut-offs
| ADHD | ASD | |||||||
|---|---|---|---|---|---|---|---|---|
| Cut-off | ≥6 | ≥12.5 | ≥4.5 | ≥8.5 | ||||
| Index twin | F** | M | F | M | F | M | F | M |
| Female co-twin | 137 (7.6) | 595 (14.2) | 17 (0.9) | 125 (3) | 40 (2.2) | 220 (5.2) | 10 (0.6) | 58 (1.4) |
| Male co-twin | 247 (5.9) | 274 (13) | 39 (0.9) | 52 (2.5) | 81 (1.9) | 103 (4.9) | 23 (0.5) | 25 (1.2) |
ADHD and autistic traits measured by the Autism—Tics, AD/HD, and other Comorbidities inventory (A-TAC)
F female index twin, M male index twin
**p = 0.01 for χ 2 analysis between female and male co-twins